Holen Sie sich die Stockscreener-App
9.62
0.73%
0.07
Schlusskurs vom Vortag:
$9.55
Offen:
$9.55
24-Stunden-Volumen:
1.27M
Relative Volume:
0.79
Marktkapitalisierung:
$3.02B
Einnahmen:
$2.68B
Nettoeinkommen (Verlust:
$-184.45M
KGV:
-14.14
EPS:
-0.6805
Netto-Cashflow:
$229.23M
1W Leistung:
+0.63%
1M Leistung:
+18.33%
6M Leistung:
+7.25%
1J Leistung:
+13.85%
1-Tages-Spanne:
$9.435
$9.64
1-Wochen-Bereich:
$9.32
$9.76
52-Wochen-Spanne:
$6.685
$9.79
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
Firmenname
Amneal Pharmaceuticals Inc
Sektor
Telefon
908-947-3120
Adresse
400 Crossing Boulevard, 3rd Floor, Bridgewater
Vergleichen Sie AMRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
9.62 | 3.00B | 2.68B | -184.45M | 229.23M | -0.6805 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-06 | Eingeleitet | Goldman | Buy |
| 2025-02-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | Hochstufung | Goldman | Sell → Buy |
| 2020-12-14 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-12-14 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-27 | Eingeleitet | Goldman | Sell |
| 2020-05-12 | Hochstufung | Guggenheim | Sell → Neutral |
| 2019-12-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-11-07 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | Eingeleitet | Barclays | Equal Weight |
| 2019-05-21 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-03-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | Herabstufung | SunTrust | Buy → Hold |
| 2018-08-13 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-06-22 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Alle ansehen
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
Should you wait for a breakout in Amneal Pharmaceuticals Inc.Bear Alert & Fast Moving Stock Trade Plans - Newser
Can machine learning forecast Amneal Pharmaceuticals Inc. recoveryPortfolio Value Summary & Stock Portfolio Risk Management - Newser
FDA Warns Amneal Pharmaceuticals Over Use of Contaminated IV Bags in Sterile Injectable Drug Production - geneonline.com
Amneal gets FDA nod for generic version of Risperdal Consta - MSN
Does Amneal Pharmaceuticals Inc. have pricing powerDollar Strength & Weekly Stock Breakout Alerts - خودرو بانک
Should you avoid Amneal Pharmaceuticals Inc. stock right nowJuly 2025 Action & Low Risk Profit Maximizing Plans - خودرو بانک
Using R and stats models for Amneal Pharmaceuticals Inc. forecastingEarnings Risk Report & Advanced Technical Signal Analysis - Newser
What is the Moat Score of Amneal Pharmaceuticals Inc.2025 Biggest Moves & Reliable Entry Point Alerts - خودرو بانک
Why Amneal Pharmaceuticals Inc. is moving todayGap Down & Smart Money Movement Alerts - Newser
FDA approves Amneal’s generic risperidone for schizophrenia treatment By Investing.com - Investing.com Australia
Is Amneal Pharmaceuticals Inc. showing insider buyingCEO Change & Free Expert Verified Stock Movement Alerts - خودرو بانک
Tools to monitor Amneal Pharmaceuticals Inc. recovery probabilityShort Setup & AI Powered Market Trend Analysis - Newser
Published on: 2025-09-05 05:42:34 - Newser
Regression analysis insights on Amneal Pharmaceuticals Inc. performanceWeekly Market Report & Accurate Intraday Trading Signals - Newser
Can Amneal Pharmaceuticals Inc. rally from current levelsWeekly Trend Report & Intraday High Probability Setup Alerts - Newser
Can technical indicators confirm Amneal Pharmaceuticals Inc.’s reversalMarket Movement Recap & Expert Curated Trade Setup Alerts - Newser
Amneal Pharmaceuticals Receives FDA Approval for Antipsychotic Medicine - AInvest
Amneal receives U.S. FDA approval for risperidone extended-release injectable suspension - MarketScreener
FDA approves Amneal’s generic risperidone for schizophrenia treatment - Investing.com
Amneal Pharmaceuticals Receives FDA Approval for Risperidone Extended-Release Injectable Suspension - Quiver Quantitative
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension - GlobeNewswire
Amneal Pharmaceuticals Receives FDA Approval for Risperidone Extended-Release Injectable Suspension, Expanding Complex Injectables Portfolio - AInvest
$194M Market Opportunity: Amneal Secures Exclusive FDA Approval for Complex Injectable Schizophrenia Drug - Stock Titan
Has Amneal Pharmaceuticals Inc. formed a bullish divergence2025 Trade Ideas & Consistent Growth Equity Picks - Newser
Detecting price anomalies in Amneal Pharmaceuticals Inc. with AIQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Will Amneal Pharmaceuticals Inc. continue its uptrendVolume Spike & Daily Volume Surge Signals - Newser
Can Amneal Pharmaceuticals Inc. expand into new marketsWeekly Investment Summary & Capital Protection Trading Alerts - خودرو بانک
Top chart patterns to watch in Amneal Pharmaceuticals Inc.Rate Hike & Breakout Confirmation Alerts - Newser
Amneal Pharmaceuticals Inc. stock trend forecast2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Is it too late to sell Amneal Pharmaceuticals Inc.2025 Winners & Losers & Daily Growth Stock Investment Tips - Newser
How hedge fund analytics apply to Amneal Pharmaceuticals Inc. stockWeekly Trading Summary & AI Enhanced Trading Signals - Newser
What are the risks of holding Amneal Pharmaceuticals Inc.2025 Geopolitical Influence & Advanced Technical Signal Analysis - khodrobank.com
Is Amneal Pharmaceuticals Inc.’s ROE strong enoughQuarterly Trade Review & Capital Efficiency Focused Strategies - خودرو بانک
Amneal Pharmaceuticals Inc. stock daily chart insightsQuarterly Earnings Summary & Fast Momentum Entry Tips - Newser
What makes Amneal Pharmaceuticals Inc. stock attractive todayPortfolio Return Report & AI Powered Buy and Sell Recommendations - خودرو بانک
Does Amneal Pharmaceuticals Inc. qualify in momentum factor screeningPortfolio Risk Report & Real-Time Volume Spike Alerts - Newser
Comparing Amneal Pharmaceuticals Inc. in custom built stock radarsGlobal Markets & Long-Term Safe Investment Plans - Newser
Is Amneal Pharmaceuticals Inc. building a consolidation basePortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
Is Amneal Pharmaceuticals Inc. forming a bullish divergenceTrade Exit Report & Long-Term Growth Plans - خودرو بانک
Published on: 2025-09-02 10:39:09 - Newser
Is Amneal Pharmaceuticals Inc. stock showing strong momentum2025 Technical Overview & Real-Time Buy Zone Alerts - خودرو بانک
Analyzing net buyer seller activity in Amneal Pharmaceuticals Inc.Exit Point & Reliable Price Breakout Alerts - Newser
Is Amneal Pharmaceuticals Inc. stock undervalued right nowInsider Buying & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Is Amneal Pharmaceuticals Inc. being accumulated by smart moneyPrice Action & AI Driven Stock Reports - khodrobank.com
Using data models to predict Amneal Pharmaceuticals Inc. stock movementTake Profit & Intraday High Probability Setup Alerts - Newser
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet - sharewise.com
Fundamentals Check: Is Amneal Pharmaceuticals Inc. a strong growth stockJuly 2025 Fed Impact & Reliable Volume Spike Trade Alerts - خودرو بانک
How to forecast Amneal Pharmaceuticals Inc. trends using time seriesEarnings Beat & Stock Portfolio Risk Control - Newser
Amneal Pharmaceuticals Inc. Approaches Support With Recovery in Sight getLinesFromResByArray error: size == 0 - 강소기업뉴스
Finanzdaten der Amneal Pharmaceuticals Inc-Aktie (AMRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):